Skip to main content

Table 2 Demographic summary by treatment group (all randomized subjects)

From: Efficacy and safety of diclofenac diethylamine 1.16% gel in acute neck pain: a randomized, double-blind, placebo-controlled study

  DDEA 1.16% gel Placebo
  (N = 36) (N = 36)
Age (years) – mean ± SD (range) 29.8 ± 10.5 (19–65) 37.8 ± 15.2 (18–74)
Sex (male) – n (%) 19 (52.8) 14 (38.9)
Time from onset of neck pain (hours) – mean ± SD (range) 246.5 ± 306.5 (23–1491) 248.4 ± 348.3 (22–1691)
Pain-on-movement* (mm) (0 = no pain, 100 = extreme pain) – mean ± SD (range) 77.2 ± 10.5 (57–92) 73.8 ± 9.8 (56–90)
Neck Disability Index score (0 = best outcome, 50 = worst outcome) – mean ± SD (range) 25.3 ± 8.4 (7–37) 23.6 ± 7.3 (9–34)
Pain-at-rest (mm) (0 = no pain, 100 = extreme pain) – mean ± SD (range) 41.1 ± 17.0 (11–79) 40.1 ± 16.9 (5–64)
  1. * Mean score, average of the three VAS scores. DDEA = diclofenac diethylamine; SD = standard deviation.